Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)

por Sekeres, M A, Swern, A S, Fenaux, P, Greenberg, P L, Sanz, G F, Bennett, J M, Dreyfus, F, List, A F, Li, J S, Sugrue, M M
Publicado 2014